- Open to Partnerships
Collaborate with Borea Therapeutics
Unlock new design possibilities for AAV therapies. We offer flexible collaboration models to accelerate innovation in gene therapy.
How We Can Work Together
Start from zero
In silico ligand scouting and design for specific characteristics
Access our ligand library
Curated options ready for conjugation
Bring your ligands
Integrate third-party ligands into our pipeline
Leverage our platform
Bio-orthogonal conjugation for any AAV capsid
Your goal, our technology — from concept to translation.
Why Partner with Borea
Flexibility
Conjugate multiple ligands to any AAV serotype, each conferring its characteristic
Translatability
No impact on AAV yield or potency – clear translational advantage with known ligands
Ligand Discovery
Start from scratch with in silico ligand scouting or leverage our library for tailored solutions.
Confidential Information
Borea Therapeutics is a company that designs and develops innovative bio-conjugated viral vectors and, as such, owns or otherwise has rights to certain confidential information related to viral vector design, reagents, methods, ligands, systems and processes, including but not limited to the conjugation of bio-active molecules to viral vector surfaces. All partnership discussions are conducted under appropriate confidentiality agreements.
Ready to Explore Partnership Opportunities?
Contact our business development team to discuss how we can collaborate to advance your gene therapy programs.
Write us at info@boreatherapeutics.it